No-Spa Forte (Drotaverine Hydrochloride)

Drotaverine blocks phosphodiesterase‑4, which raises intracellular cAMP levels. The increased cAMP reduces calcium entry into smooth‑muscle cells, leading to relaxation of visceral and vascular smooth muscle and thereby alleviating spasm‑related pain.

The appropriate dose of No-Spa Forte is determined by the prescribing healthcare professional based on the patient’s condition, age, weight and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for drotaverine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other antispasmodics such as hyoscine or papaverine, drotaverine has a selective phosphodiesterase‑4 inhibitory action, which may result in fewer anticholinergic side effects like dry mouth or blurred vision. However, therapeutic choice depends on the specific clinical scenario and physician judgment.

No-Spa Forte should be stored at room temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Do not store in a refrigerator or freezer unless otherwise specified by the manufacturer.

No-Spa Forte is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless directed by a healthcare professional. Administration timing (e.g., with or without food) follows the prescriber’s guidance.

Serious risks, though rare, include severe allergic reactions such as rash, urticaria or angioedema, and significant hypotension that can lead to fainting. Patients should seek immediate medical attention if they experience any signs of an allergic reaction or sudden drop in blood pressure.

Patients with known hypersensitivity to drotaverine or any excipients in the tablet should avoid using No-Spa Forte. Additionally, individuals with uncontrolled hypotension, severe hepatic impairment, or those taking contraindicated medications should not use this product without medical supervision.